- August 31, 2021
- Vineti
- Posted in Commercial Scale
Key industry and government regulations provide a cybersecurity foundation in advanced therapies
Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…
- August 24, 2021
- Vineti
- Posted in Commercial Scale
Cybersecurity success in advanced therapies starts by prioritizing security as a “Way of working”
Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…
- August 17, 2021
- Vineti
- Posted in Commercial Scale
Cybersecurity challenges in advanced therapies — introducing five strategies for success
Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…
- August 13, 2021
- Vineti
- Posted in Company Updates
Lykan Bioscience and Vineti Announce Partnership to Advance Cell-based Therapies from Clinical to Commercialization
Lykan Bioscience’s world-class manufacturing capabilities, integrated with Vineti’s leading digital enterprise platform for cell and gene therapy supply chains, will streamline process development and manufacturing…
- August 11, 2021
- Vineti
- Posted in Company Updates
Vineti announces agreement with Imvax to utilize Vineti’s PTM Essentials™ solution
Vineti’s enterprise technology will enable critical patient-specific Chain of Custody management for Imvax, supporting Imvax’s goal of reaching more patients as fast as possible